Monitoring for breast cancer after childhood chest radiation: When and how?

July 08, 2020

Chest radiation is used to treat children with Hodgkin and non-Hodgkin lymphoma as well as lung metastases in various solid tumors. But radiation itself is a potential cancer risk, including an increased risk for breast cancer later in life. Girls receiving chest radiation for childhood cancer face a breast cancer risk as high as 30 percent by age 50.

What is the best strategy for catching these breast cancers early? Annual screening with mammography and breast MRI is recommended, but practices vary from location to location, and the benefits, harms, and costs are unclear. A new study led by Jennifer M. Yeh, PhD, in the Division of General Pediatrics at Boston Children's Hospital, used modeling to compare results of different approaches. The findings appear in the Annals of Internal Medicine.

"Randomized clinical trials are often thought of as the 'gold standard,' but they aren't always feasible for screening studies, especially in rare high risk groups such as survivors of childhood cancer," Yeh says. "However, those developing guidelines need information on the potential benefits and harms of screening. Decision modeling can provide important insight on these health outcomes."

Yeh, with collaborators across the country, used two breast cancer simulation models that were developed to guide screening recommendations for women who are not cancer survivors. The two models, part of the Cancer Intervention and Surveillance Modeling Network (CISNET), were adapted using information from the Childhood Cancer Survivor Study (CCSS). The CCSS is a cohort study on outcomes, including breast cancer, in more than 24,000 survivors of childhood and adolescent cancers diagnosed between 1970 and 1999.

The models evaluated the following annual screening strategies:The models assumed that women who were screened continued to be screened until age 74, and that those diagnosed with breast cancer received the best therapy available at the time.

All annual screening approaches save lives

In the simulation, Yeh showed that without screening, childhood cancer survivors previously treated with chest radiation had a 10 to 11 percent lifetime risk of dying from breast cancer, as compared with a 2.5 percent risk among women in the general population.

Compared with no screening, all annual screening strategies prevented more than half of breast cancer deaths according to the models. A combined approach of both breast MRI and mammography, beginning at age 25, prevented the most deaths (an estimated 56 to 71 percent); MRI alone prevented slightly fewer (56 to 62 percent).

However, starting at age 25 also meant more screening tests, more false-positive findings, and more breast biopsies that turned out to be benign. For example, the researchers estimate that the average survivor screened with both MRI and mammography would have four to five false-positive screens and one to two breast biopsies over the course of her lifetime.

When the emotional stress and costs of additional screening and testing were factored into the analysis, starting at age 30 was the preferred strategy; relatively little was gained by starting at age 25. Either strategy reduced the risk of dying from breast cancer by at least half, with or without the addition of mammography to MRI.

Interpreting the findings

Lisa Diller, MD, chief medical officer of the Dana-Farber/Boston Children's Cancer and Blood Disorders Center, is an expert in the care of childhood cancer survivors and a co-author of the study. "Breast cancer screening is one of the most important issues that oncologists should discuss with survivors of childhood chest radiation," Diller says. "Having these data informs discussions with young women who are facing screening at a very young age. It both reassures them that waiting until age 30 might be reasonable and impresses upon them that this screening could be life-saving."

One limitation of the study was that it used data from childhood cancer survivors diagnosed between 1970 and 1986. Since then, cancer treatment has changed, including decreased doses and improved delivery of radiation, and breast cancer monitoring now includes digital breast tomosynthesis, also known as 3D mammography.

"Our model-based findings suggest that even if the risk of breast cancer declines by half with more recent changes in radiation dose and delivery, early initiation of screening still remains favorable for these high-risk survivors," Yeh says. "Ensuring survivors are aware of and have access to screening can save lives."
The study was funded by the American Cancer Society, the National Cancer Institute, a Cancer Center Support grant and the American Lebanese-Syrian Associated Charities.

Boston Children's Hospital

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to